U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 411

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr12:52306249-52314687
GRCh38:
Chr12:51912465-51920903
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 4, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr12:52306271-52306272
GRCh38:
Chr12:51912487-51912488
ACVRL1R7fsCardiovascular phenotypePathogenic
(Jul 11, 2018)
criteria provided, single submitter
3.
GRCh37:
Chr12:52306295
GRCh38:
Chr12:51912511
ACVRL1L13fsPulmonary arterial hypertension related to hereditary hemorrhagic telangiectasiaPathogenicno assertion criteria provided
4.
GRCh37:
Chr12:52306298-52306299
GRCh38:
Chr12:51912514-51912515
ACVRL1M15fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jul 3, 2017)
criteria provided, single submitter
5.
GRCh37:
Chr12:52306306-52306307
GRCh38:
Chr12:51912522-51912523
ACVRL1L17fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 14, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr12:52306316
GRCh38:
Chr12:51912532
ACVRL1Q20*Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jan 16, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr12:52306320
GRCh38:
Chr12:51912536
ACVRL1not providedLikely pathogenic
(Jan 23, 2023)
criteria provided, single submitter
8.
GRCh37:
Chr12:52306320
GRCh38:
Chr12:51912536
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Feb 5, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr12:52306847-52306887
GRCh38:
Chr12:51913063-51913103
ACVRL1Cardiovascular phenotypeLikely pathogenic
(Apr 22, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr12:52306863-52307574
GRCh38:
Chr12:51913079-51913790
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Nov 18, 2017)
criteria provided, single submitter
11.
GRCh37:
Chr12:52306886
GRCh38:
Chr12:51913102
ACVRL1D22fsCardiovascular phenotypePathogenic
(Sep 22, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr12:52306887
GRCh38:
Chr12:51913103
ACVRL1P23fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Dec 10, 2021)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr12:52306889-52306911
GRCh38:
Chr12:51913105-51913127
ACVRL1V24fsCardiovascular phenotypePathogenic
(Jul 5, 2019)
criteria provided, single submitter
14.
GRCh37:
Chr12:52306891-52306898
GRCh38:
Chr12:51913107-51913114
ACVRL1K25fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Sep 16, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr12:52306894
GRCh38:
Chr12:51913110
ACVRL1K25*Cardiovascular phenotypePathogenic
(Apr 9, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr12:52306895-52306898
GRCh38:
Chr12:51913111-51913114
ACVRL1Cardiovascular phenotypePathogenic
(Sep 11, 2020)
criteria provided, single submitter
17.
GRCh37:
Chr12:52306899-52306902
GRCh38:
Chr12:51913115-51913118
ACVRL1S27fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jun 27, 2020)
criteria provided, single submitter
18.
GRCh37:
Chr12:52306904
GRCh38:
Chr12:51913120
ACVRL1G29fsTelangiectasia, hereditary hemorrhagic, type 2, not providedPathogenic
(Aug 13, 2021)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr12:52306920-52306921
GRCh38:
Chr12:51913136-51913137
ACVRL1C34fsCardiovascular phenotypePathogenic
(Aug 17, 2021)
criteria provided, single submitter
20.
GRCh37:
Chr12:52306921
GRCh38:
Chr12:51913137
ACVRL1C34RTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(May 24, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr12:52306922
GRCh38:
Chr12:51913138
ACVRL1C34YTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic/Likely pathogenic
(Dec 2, 2021)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr12:52306923
GRCh38:
Chr12:51913139
ACVRL1C34*Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jul 31, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr12:52306926
GRCh38:
Chr12:51913142
ACVRL1C36fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jul 17, 2017)
criteria provided, single submitter
24.
GRCh37:
Chr12:52306927
GRCh38:
Chr12:51913143
ACVRL1C36RTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Aug 28, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr12:52306935-52306936
GRCh38:
Chr12:51913151-51913152
ACVRL1P39fsTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Apr 24, 2020)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr12:52306942
GRCh38:
Chr12:51913158
ACVRL1C41GTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 26, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr12:52306943
GRCh38:
Chr12:51913159
ACVRL1C41YTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Jul 14, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr12:52306946-52306947
GRCh38:
Chr12:51913162-51913163
ACVRL1P44fsTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Nov 14, 2019)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr12:52306947-52306962
GRCh38:
Chr12:51913163-51913178
ACVRL1T45fsCardiovascular phenotypePathogenic
(May 13, 2015)
criteria provided, single submitter
30.
GRCh37:
Chr12:52306947-52306960
GRCh38:
Chr12:51913163-51913176
ACVRL1P44fsTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Apr 14, 2021)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr12:52306949-52306953
GRCh38:
Chr12:51913165-51913169
ACVRL1G43fsCardiovascular phenotypePathogenic
(Apr 14, 2019)
criteria provided, single submitter
32.
GRCh37:
Chr12:52306951-52306967
GRCh38:
Chr12:51913167-51913183
ACVRL1P44fsCardiovascular phenotypePathogenic
(Dec 2, 2019)
criteria provided, single submitter
33.
GRCh37:
Chr12:52306952-52306953
GRCh38:
Chr12:51913168-51913169
ACVRL1C46fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Dec 7, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr12:52306953
GRCh38:
Chr12:51913169
ACVRL1C46fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Oct 22, 2019)
criteria provided, single submitter
35.
GRCh37:
Chr12:52306958-52306959
GRCh38:
Chr12:51913174-51913175
ACVRL1R47fsTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Jan 1, 2018)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr12:52306960-52306961
GRCh38:
Chr12:51913176-51913177
ACVRL1R47fsnot provided, Cardiovascular phenotypePathogenic
(May 31, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr12:52306960-52306961
GRCh38:
Chr12:51913176-51913177
ACVRL1A49fsTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype, not provided
Pathogenic
(Jan 4, 2023)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr12:52306961
GRCh38:
Chr12:51913177
ACVRL1A49fsCardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr12:52306961
GRCh38:
Chr12:51913177
ACVRL1R47PCardiovascular phenotype, not provided, Telangiectasia, hereditary hemorrhagic, type 2
Pathogenic/Likely pathogenic
(Aug 20, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr12:52306963
GRCh38:
Chr12:51913179
ACVRL1G48RTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 27, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr12:52306964
GRCh38:
Chr12:51913180
ACVRL1G48ECardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic/Likely pathogenic
(Apr 18, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr12:52306964-52306968
GRCh38:
Chr12:51913180-51913184
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(May 1, 2000)
no assertion criteria provided
43.
GRCh37:
Chr12:52306969
GRCh38:
Chr12:51913185
ACVRL1W50GTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Apr 28, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr12:52306969
GRCh38:
Chr12:51913185
ACVRL1W50RHereditary hemorrhagic telangiectasia, Telangiectasia, hereditary hemorrhagic, type 2, Telangiectasia, hereditary hemorrhagic, type 2
Likely pathogenic
(Jan 20, 2023)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr12:52306971
GRCh38:
Chr12:51913187
ACVRL1W50CTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 21, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr12:52306971
GRCh38:
Chr12:51913187
ACVRL1W50CCardiovascular phenotype, not provided, Telangiectasia, hereditary hemorrhagic, type 2
Pathogenic
(May 18, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr12:52306972
GRCh38:
Chr12:51913188
ACVRL1C51STelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(May 1, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr12:52306973
GRCh38:
Chr12:51913189
ACVRL1C51YTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype, not provided
Pathogenic
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr12:52306975
GRCh38:
Chr12:51913191
ACVRL1T52PCardiovascular phenotypeLikely pathogenic
(Sep 26, 2016)
criteria provided, single submitter
50.
GRCh37:
Chr12:52306997-52306998
GRCh38:
Chr12:51913213-51913214
ACVRL1R61fsCardiovascular phenotypePathogenic
(Jul 5, 2016)
criteria provided, single submitter
51.
GRCh37:
Chr12:52307003
GRCh38:
Chr12:51913219
ACVRL1R61fsTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Aug 13, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr12:52307007
GRCh38:
Chr12:51913223
ACVRL1Q64fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Oct 8, 2016)
criteria provided, single submitter
53.
GRCh37:
Chr12:52307011
GRCh38:
Chr12:51913227
ACVRL1Q64*Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jan 29, 2019)
criteria provided, single submitter
54.
GRCh37:
Chr12:52307013
GRCh38:
Chr12:51913229
ACVRL1E65fsCardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Apr 12, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr12:52307014
GRCh38:
Chr12:51913230
ACVRL1E65*Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr12:52307020
GRCh38:
Chr12:51913236
ACVRL1R67Gnot providedLikely pathogenic
(Sep 23, 2019)
criteria provided, single submitter
57.
GRCh37:
Chr12:52307020
GRCh38:
Chr12:51913236
ACVRL1R67WCardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2, not provided,
Abnormality of the pulmonary vasculature
Pathogenic/Likely pathogenic
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr12:52307021
GRCh38:
Chr12:51913237
ACVRL1R67PTelangiectasia, hereditary hemorrhagic, type 1Likely pathogenicno assertion criteria provided
59.
GRCh37:
Chr12:52307021
GRCh38:
Chr12:51913237
ACVRL1R67Qnot provided, Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype
Pathogenic/Likely pathogenic
(Nov 25, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr12:52307026
GRCh38:
Chr12:51913242
ACVRL1C69RCardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jul 13, 2021)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr12:52307027
GRCh38:
Chr12:51913243
ACVRL1C69YTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Apr 22, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr12:52307027
GRCh38:
Chr12:51913243
ACVRL1C69Fnot provided, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic/Likely pathogenic
(Jun 25, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr12:52307028
GRCh38:
Chr12:51913244
ACVRL1C69*Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Sep 30, 2019)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr12:52307031-52307034
GRCh38:
Chr12:51913247-51913250
ACVRL1L72fsCardiovascular phenotypePathogenic
(Jan 17, 2020)
criteria provided, single submitter
65.
GRCh37:
Chr12:52307042
GRCh38:
Chr12:51913258
ACVRL1E75fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 26, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr12:52307044
GRCh38:
Chr12:51913260
ACVRL1E75*Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jun 23, 2019)
criteria provided, single submitter
67.
GRCh37:
Chr12:52307050
GRCh38:
Chr12:51913266
ACVRL1C77RCardiovascular phenotypeLikely pathogenic
(Sep 26, 2016)
criteria provided, single submitter
68.
GRCh37:
Chr12:52307052
GRCh38:
Chr12:51913268
ACVRL1C77WTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 27, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr12:52307053-52307054
GRCh38:
Chr12:51913269-51913270
ACVRL1R80fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Dec 3, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr12:52307054
GRCh38:
Chr12:51913270
ACVRL1R80fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jan 3, 2019)
criteria provided, single submitter
71.
GRCh37:
Chr12:52307056
GRCh38:
Chr12:51913272
ACVRL1G79RCardiovascular phenotypeLikely pathogenic
(Mar 12, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr12:52307057
GRCh38:
Chr12:51913273
ACVRL1G79ECardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Aug 25, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr12:52307060-52307061
GRCh38:
Chr12:51913276-51913277
ACVRL1T82fsCardiovascular phenotypePathogenic
(Oct 16, 2020)
criteria provided, single submitter
74.
GRCh37:
Chr12:52307079
GRCh38:
Chr12:51913295
ACVRL1H87fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jan 1, 2018)
criteria provided, single submitter
75.
GRCh37:
Chr12:52307085
GRCh38:
Chr12:51913301
ACVRL1Y88*not providedPathogenic
(Aug 24, 2017)
criteria provided, single submitter
76.
GRCh37:
Chr12:52307086
GRCh38:
Chr12:51913302
ACVRL1C89GTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr12:52307086
GRCh38:
Chr12:51913302
ACVRL1C89RCardiovascular phenotype, not specified, Telangiectasia, hereditary hemorrhagic, type 2
Pathogenic/Likely pathogenic
(Dec 6, 2021)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr12:52307087
GRCh38:
Chr12:51913303
ACVRL1C89FTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Jul 11, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr12:52307088
GRCh38:
Chr12:51913304
ACVRL1C89WTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr12:52307090
GRCh38:
Chr12:51913306
ACVRL1C90FTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic/Likely pathogenic
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr12:52307090
GRCh38:
Chr12:51913306
ACVRL1C90YTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype, not provided
Pathogenic/Likely pathogenic
(Aug 14, 2020)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr12:52307091
GRCh38:
Chr12:51913307
ACVRL1C90WCardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic/Likely pathogenic
(Jul 4, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr12:52307091
GRCh38:
Chr12:51913307
ACVRL1C90*Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic/Likely pathogenic
(Apr 29, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr12:52307092
GRCh38:
Chr12:51913308
ACVRL1D91fsnot specifiedPathogenic
(Sep 20, 2016)
criteria provided, single submitter
85.
GRCh37:
Chr12:52307107
GRCh38:
Chr12:51913323
ACVRL1N96DTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Oct 14, 2020)
criteria provided, single submitter
86.
GRCh37:
Chr12:52307108
GRCh38:
Chr12:51913324
ACVRL1N96SCardiovascular phenotypeLikely pathogenic
(Sep 16, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr12:52307115-52307119
GRCh38:
Chr12:51913331-51913335
ACVRL1V99fsnot providedPathogenic
(Mar 21, 2017)
criteria provided, single submitter
88.
GRCh37:
Chr12:52307123
GRCh38:
Chr12:51913339
ACVRL1L101fsnot providedLikely pathogenic
(Dec 13, 2016)
criteria provided, single submitter
89.
GRCh37:
Chr12:52307131
GRCh38:
Chr12:51913347
ACVRL1E104*Cardiovascular phenotypePathogenic
(Mar 3, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr12:52307133-52307134
GRCh38:
Chr12:51913349-51913350
ACVRL1Cardiovascular phenotypeLikely pathogenic
(May 18, 2020)
criteria provided, single submitter
91.
GRCh37:
Chr12:52307135
GRCh38:
Chr12:51913351
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 17, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr12:52307135
GRCh38:
Chr12:51913351
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Dec 9, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr12:52307136
GRCh38:
Chr12:51913352
ACVRL1Cardiovascular phenotypeLikely pathogenic
(Nov 18, 2015)
criteria provided, single submitter
94.
GRCh37:
Chr12:52307323-52312919
GRCh38:
Chr12:51913539-51919135
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Apr 3, 2018)
criteria provided, single submitter
95.
GRCh37:
Chr12:52307358
GRCh38:
Chr12:51913574
ACVRL1S110*Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 23, 2020)
criteria provided, single submitter
96.
GRCh37:
Chr12:52307363
GRCh38:
Chr12:51913579
ACVRL1Q112*Cardiovascular phenotypePathogenic
(May 11, 2016)
criteria provided, single submitter
97.
GRCh37:
Chr12:52307365
GRCh38:
Chr12:51913581
ACVRL1Q112fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Sep 12, 2019)
criteria provided, single submitter
98.
GRCh37:
Chr12:52307376-52307377
GRCh38:
Chr12:51913592-51913593
ACVRL1L121fsCardiovascular phenotypePathogenic
(May 30, 2018)
criteria provided, single submitter
99.
GRCh37:
Chr12:52307381
GRCh38:
Chr12:51913597
ACVRL1Q118*Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Nov 27, 2019)
criteria provided, single submitter
100.
GRCh37:
Chr12:52307386-52307398
GRCh38:
Chr12:51913602-51913614
ACVRL1L121fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Mar 9, 2020)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination